527 related articles for article (PubMed ID: 10930856)
61. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
[TBL] [Abstract][Full Text] [Related]
62. Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients.
Jorizzo J; Levy M; Lucky A; Shavin J; Goldberg G; Dunlap F; Hinds A; Strelka L; Baker M; Tuley M
J Am Acad Dermatol; 1995 Jul; 33(1):74-7. PubMed ID: 7601950
[TBL] [Abstract][Full Text] [Related]
63. A randomized double-blind controlled trial to compare a triclosan-containing emollient with vehicle for the treatment of atopic dermatitis.
Tan WP; Suresh S; Tey HL; Chiam LY; Goon AT
Clin Exp Dermatol; 2010 Jun; 35(4):e109-12. PubMed ID: 19843084
[TBL] [Abstract][Full Text] [Related]
64. Halometasone cream by day and halometasone ointment at night for the treatment of patients with chronic psoriasis vulgaris.
Galbiati G; Bonfacini V; Candiani F
J Int Med Res; 1983; 11 Suppl 1():31-3. PubMed ID: 6339290
[TBL] [Abstract][Full Text] [Related]
65. Mometasone versus betamethasone creams: a trial in dermatoses.
Wishart JM; Lee IS
N Z Med J; 1993 May; 106(956):203-5. PubMed ID: 8341439
[TBL] [Abstract][Full Text] [Related]
66. Evaluation of halometasone ointment in the treatment of paediatric patients with chronic eczematous dermatoses.
Herz G; Yawalkar SJ; Weirich EG
J Int Med Res; 1983; 11 Suppl 1():21-5. PubMed ID: 6339288
[TBL] [Abstract][Full Text] [Related]
67. Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial.
Saraceno R; Andreassi L; Ayala F; Bongiorno MR; Giannetti A; Lisi P; Martini P; Peris K; Peserico A; Chimenti S
J Dermatolog Treat; 2007; 18(6):361-5. PubMed ID: 17934937
[TBL] [Abstract][Full Text] [Related]
68. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
69. Emollients improve treatment results with topical corticosteroids in childhood atopic dermatitis: a randomized comparative study.
Szczepanowska J; Reich A; Szepietowski JC
Pediatr Allergy Immunol; 2008 Nov; 19(7):614-8. PubMed ID: 18208463
[TBL] [Abstract][Full Text] [Related]
70. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
[TBL] [Abstract][Full Text] [Related]
71. An overview of international clinical trials with halometasone ointment in chronic eczematous dermatoses.
Yawalkar SJ; Macarol V; Montanari C
J Int Med Res; 1983; 11 Suppl 1():13-20. PubMed ID: 6339287
[TBL] [Abstract][Full Text] [Related]
72. Desonide foam: a review.
Parish D; Scheinfeld N
Drugs Today (Barc); 2008 Jan; 44(1):55-62. PubMed ID: 18301804
[TBL] [Abstract][Full Text] [Related]
73. Pimecrolimus: new preparation. Me-too: too many risks, not beneficial enough in atopic dermatitis.
Prescrire Int; 2004 Dec; 13(74):209-12. PubMed ID: 15599989
[TBL] [Abstract][Full Text] [Related]
74. Adrenocortical function during prolonged treatment with clobetasone butyrate in children with chronic atopic dermatitis and elevated IgE levels.
Boner AL; Richelli C; De Stefano G; Antolini I; Aprili F; Mengoni M
Int J Clin Pharmacol Res; 1985; 5(2):127-31. PubMed ID: 4018942
[TBL] [Abstract][Full Text] [Related]
75. Evaluation of a new moisturizer (Exomega milk) in children with atopic dermatitis.
Giordano-Labadie F; Cambazard F; Guillet G; Combemale P; Mengeaud V
J Dermatolog Treat; 2006; 17(2):78-81. PubMed ID: 16766330
[TBL] [Abstract][Full Text] [Related]
76. Clinical comparison of desonide cream with betamethasone valerate cream. A double-blind randomized study.
Bluefarb SM
Int J Dermatol; 1972; 11(2):73-6. PubMed ID: 4554183
[No Abstract] [Full Text] [Related]
77. Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis.
Sigurgeirsson B; Ho V; Ferrándiz C; Andriano K; Grinienko A; Jimenez P;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1290-301. PubMed ID: 18624866
[TBL] [Abstract][Full Text] [Related]
78. A pilot study on the use of wet wraps in infants with moderate atopic eczema.
Beattie PE; Lewis-Jones MS
Clin Exp Dermatol; 2004 Jul; 29(4):348-53. PubMed ID: 15245526
[TBL] [Abstract][Full Text] [Related]
79. Addition of topical pimecrolimus to once-daily mid-potent steroid confers no short-term therapeutic benefit in the treatment of severe atopic dermatitis; a randomized controlled trial.
Spergel JM; Boguniewicz M; Paller AS; Hebert AA; Gallagher PR; McCormick C; Parneix-Spake A; Hultsch T
Br J Dermatol; 2007 Aug; 157(2):378-81. PubMed ID: 17573885
[TBL] [Abstract][Full Text] [Related]
80. Effects of pimecrolimus cream 1% in the treatment of patients with atopic dermatitis who demonstrate a clinical insensitivity to topical corticosteroids: a randomized, multicentre vehicle-controlled trial.
Leung DY; Hanifin JM; Pariser DM; Barber KA; Langley RG; Schlievert PM; Abrams B; Hultsch T
Br J Dermatol; 2009 Aug; 161(2):435-43. PubMed ID: 19416245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
